Dr. Issaka serves as a key member of the colorectal cancer screening workgroup of the statutorily mandated Bree Collaborative. This workgroup proposes evidence-based recommendations to (1) change Washington State's healthcare purchasing guidelines and (2) develop general recommendations to improve patient health, healthcare service quality and the affordability of healthcare in Washington State.

(More Info)

Dr. Issaka served as Measure Steward for fecal immunochemical test (FIT) follow-up in California safety net hospitals for the California Public Hospital Redesign and Incentives in Medi-Cal (PRIME) program. Cal-PRIME is a pay-for-performance program in which California’s public health care systems and District and Municipal Hospitals are using evidence-based quality improvement methods to achieve ambitious performance targets and improve health outcomes for patients.

(More Info)

Dr. Issaka's perspective article describing the colorectal cancer screening landscape with COVID-19 and providing recommendations for how primary care physicians and gastroenterologists can maintain momentum in their efforts to decrease colorectal cancer mortality within health care organizations despite the challenges of the pandemic.

(More Info)

Dr. Issaka's perspective article highlighting the need to proactively identify and mitigate unintended consequences of the COVID-19 pandemic response to make progress on existing health priorities and prevent the resurgence of other infectious and chronic diseases.

(More Info)